Form 13-F position report

IGM BIOSCIENCES INC COM

Reported by Candriam S C A

IGMS CUSIP 449585108 Manager CIK 0001537014

First reported at 48,760 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q3 2022
Shares 48,760 Quarter-end amount reported
Reported value $1,109,000 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 0
2022-09-30 1109000
2022-12-31 2704208
2023-03-31 2375050
2023-06-30 1615324
2023-09-30 1461317
2023-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for IGM BIOSCIENCES INC COM held by Candriam S C A.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2023 Reduced 0 -175,008 (-100.0%) 0 $0 2024-02-14
Q3 2023 Unchanged 175,008 0 (0.0%) 0.01% $1,461,317 2023-11-13
Q2 2023 Reduced 175,008 -12,791 (-6.8%) 0.01% $1,615,324 2023-08-08
Q1 2023 Added 187,799 +28,814 (18.1%) 0.02% $2,375,050 2023-05-12
Q4 2022 Added 158,985 +110,225 (226.1%) 0.02% $2,704,208 2023-02-13
Q3 2022 New 48,760 +48,760 (0.0%) < 0.01% $1,109,000 2022-11-10
Q3 2021 Reduced 0 -122,029 (-100.0%) 0 $0 2021-11-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

106 managers reported IGM BIOSCIENCES INC COM for Q3 2022.

Managers reporting IGM BIOSCIENCES INC COM in Q3 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Redmile Group LLC Unchanged 3,334,355 0 2.94% $75,823,000 13 qtrs
BAKER BROS ADVISORS LP Unchanged 3,156,102 0 0.47% $71,770,000 13 qtrs
Artal Group S A Added 2,450,000 +450,000 2.38% $55,713,000 9 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 2,217,766 -405,107 < 0.01% $50,433,000 13 qtrs
ALKEON CAPITAL MANAGEMENT LLC Reduced 961,613 -72,422 0.07% $21,867,000 11 qtrs
BlackRock Inc Added 739,906 +16,196 < 0.01% $16,826,000 13 qtrs
T Rowe Price Investment Management Inc New 586,663 +586,663 0.01% $13,341,000 1 qtr
UBS ASSET MANAGEMENT AMERICAS INC Reduced 524,311 -12,098 < 0.01% $11,922,833 10 qtrs
VANGUARD GROUP INC Added 519,977 +9,044 < 0.01% $11,824,000 13 qtrs
D E Shaw & Co Inc Added 337,170 +62,616 < 0.01% $7,667,000 8 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
November 10, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
48,760
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.